In the original publication [1], there was a mistake in Figure 5 as published. During the assembly of the representative panel, the condition “dexamethasone + glucoraphanin” of carbonylated proteins and the house-keeping protein β-Actin were unintentionally represented by wrong images. The corrected Figure 5 appears below.
Figure 5.
Protein carbonylation in C2C12 myotubes. C2C12 myotubes were treated for 48 h with 1 μM DEX, both alone and in the presence of 30 μM glucoraphanin, 150 μM L-cysteine and 150 μM mercaptopyruvate. Western blot analysis was carried out on cell homogenates using a specific antibody against DNPH. Figures show the densitometric analysis (top) and the illustrative immunoblot (bottom). Each sample was normalized to β-Actin expression. Values are expressed % of integrated density and calculated as mean ± S.E.M. of 3 different experiments. ** p < 0.01 versus control; ^ p < 0.05 and ^^ p < 0.01 versus DEX.
The authors state that the scientific conclusions are unaffected. This correction was approved by the academic editor. The original publication has also been updated.
Reference
- Micheli, L.; Mitidieri, E.; Turnaturi, C.; Vanacore, D.; Ciampi, C.; Lucarini, E.; Cirino, G.; Ghelardini, C.; Sorrentino, R.; Di Cesare Mannelli, L.; et al. Beneficial Effect of H2S-Releasing Molecules in an In Vitro Model of Sarcopenia: Relevance of Glucoraphanin. Int. J. Mol. Sci. 2022, 23, 5955. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).